bioMérieux S.A.

DB:EYWN Stock Report

Market Cap: €11.6b

bioMérieux Future Growth

Future criteria checks 2/6

bioMérieux is forecast to grow earnings and revenue by 13.6% and 7.3% per annum respectively. EPS is expected to grow by 13.5% per annum. Return on equity is forecast to be 12.8% in 3 years.

Key information

13.6%

Earnings growth rate

13.5%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate7.3%
Future return on equity12.8%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:EYWN - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,56260741690612
12/31/20254,23353638383913
12/31/20243,94847442077614
6/30/20243,807411156495N/A
3/31/20243,741384132470N/A
12/31/20233,675358107445N/A
9/30/20233,688372140459N/A
6/30/20233,701386172472N/A
3/31/20233,645419180474N/A
12/31/20223,589452188475N/A
9/30/20223,525502297583N/A
6/30/20223,460552406690N/A
3/31/20223,418577470757N/A
12/31/20213,376601535825N/A
9/30/20213,296555424716N/A
6/30/20213,216509314608N/A
3/31/20213,167457310595N/A
12/31/20203,118404305583N/A
9/30/20202,997355261538N/A
6/30/20202,876305217493N/A
3/31/20202,775289176451N/A
12/31/20192,675273135408N/A
9/30/20192,601268160419N/A
6/30/20192,527263185431N/A
3/31/20192,474260179415N/A
12/31/20182,421257173400N/A
9/30/20182,372264162370N/A
6/30/20182,323271150340N/A
3/31/20182,306255N/A341N/A
12/31/20172,288238N/A341N/A
9/30/20172,262216N/A340N/A
6/30/20172,237195N/A339N/A
3/31/20172,170187N/A337N/A
12/31/20162,103179N/A336N/A
9/30/20162,068158N/A339N/A
6/30/20162,032137N/A342N/A
3/31/20161,998124N/A326N/A
12/31/20151,965111N/A310N/A
9/30/20151,908127N/AN/AN/A
6/30/20151,851144N/A301N/A
3/31/20151,775140N/A300N/A
12/31/20141,698135N/A298N/A
9/30/20141,656135N/AN/AN/A
6/30/20141,614135N/A246N/A
3/31/20141,601150N/A243N/A
12/31/20131,588164N/A241N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EYWN's forecast earnings growth (13.6% per year) is above the savings rate (1%).

Earnings vs Market: EYWN's earnings (13.6% per year) are forecast to grow slower than the German market (21.1% per year).

High Growth Earnings: EYWN's earnings are forecast to grow, but not significantly.

Revenue vs Market: EYWN's revenue (7.3% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: EYWN's revenue (7.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: EYWN's Return on Equity is forecast to be low in 3 years time (12.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y